THE FUTURE FIBROMYALGIA DRUGS?
PHARMACEUTICAL SOURCE PREDICTS FOUR DRUG APPROVALS IN COMING YEARS
Both Sleep and Pain Improved
“Our new analyses of the BESTFIT data show that those patients who reported the greatest improvement in sleep quality were the most likely to experience pain relief,” Seth Lederman, MD, Tonix CEO
Tonix – the developer of the drug – is moving fast. They reported that their Phase II clinical trial for Tonmya was filled in June of this year and reported results on the trial last month.They’ve already begun final (Phase III) trials.
A former study using EEG indicated the drug was increasing restorative sleep, which in turn was associated with reductions in pain, fatigue and depression. In a good sign for those in really severe pain, the most recent studies tied together pain levels and sleep quality; those FM patients in the most pain received the most improvements in sleep quality.
Dr. Lederman, Tonix CEO, emphasized that the drug is not a sleeping pill; it doesn’t just knock you out – it improves sleep quality.
To Read More, please click this link: